Cov Pars causes 9-12 months immunity to COVID-19

Total:2

  • Cov Pars begins clinical trial on adolescents 2022-02-20 18:42

    Cov Pars begins clinical trial on adolescents

    TEHRAN – The domestically-made Cov Pars Razi vaccine has received the license for a clinical trial on adolescents, Mehr news agency reported on Sunday.

  • Cov Pars causes 9-12 months immunity to COVID-19 2021-11-14 19:00

    Cov Pars causes 9-12 months immunity to COVID-19

    TEHRAN – Studies show that Cov Pars vaccine, developed by the Razi Vaccine and Serum Research Institute of Iran, makes immunity for 9-12 months against the coronavirus, Reza Bani-Hashemi, the director for research and development at the institute, said on Sunday.